1. AXIN2 is Associated With Papillary Thyroid Carcinoma
   Xin Liu et al, 2016, Iran Red Crescent Med J CrossRef
2. Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis
   Lin Zhang et al, 2015, CARCIN CrossRef
3. Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants
   Tomasz Stokowy et al, 2016, International Journal of Endocrinology CrossRef
4. MicroRNA-299-3p suppresses proliferation and invasion by targeting VEGFA in human colon carcinoma
   Jia-yong Wang et al, 2017, Biomedicine & Pharmacotherapy CrossRef
5. Role of microRNAs in endocrine cancer metastasis
   Cilene Rebouças Lima et al, 2017, Molecular and Cellular Endocrinology CrossRef
6. Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes
   J Jonklaas et al, 2017, Future Science OA CrossRef
7. Noncoding RNAs as a Cause of Cancer
   Juan Cui, 2018 CrossRef
8. Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease
   Keith Richard Mitchelson, 2015, WJBC CrossRef
9. miR-101 inhibits cell proliferation by targeting Rac1 in papillary thyroid carcinoma
   XIAOJIE LIN et al, 2014 CrossRef
10. The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma
    YINLONG ZHAO et al, 2015 CrossRef
11. Cancer stem cells as a potential therapeutic target in thyroid carcinoma
    Luisa Vicari et al, 2016 CrossRef
12. Expression Profile and Clinical Significance of MicroRNAs in Papillary Thyroid Carcinoma
    You Peng et al, 2014, Molecules CrossRef
13. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma
    Shan Dang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
14. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia
    Xin-Yue Lian et al, 2018, J Cell Physiol CrossRef
15. Shenmai injection improves the postoperative immune function of papillary thyroid carcinoma patients by inhibiting differentiation into Treg cells via miR-103/GPER1 axis.
    Tie Fang et al, 2018, Drug Dev Res CrossRef
16. Identification of key genes and miRNAs markers of papillary thyroid cancer
    Jie Qiu et al, 2018, Biol Res CrossRef
17. Microrna-1/206 Target both Monocarboxylate Transporter(MCT)-4 and Vascular Endothelial Growth Factor(VEGF)Genes Leading to Inhibition of Tumor Growth
    Anas Khaleel et al, 2018 CrossRef
18. MicroRNA-103a-3p controls proliferation and osteogenic differentiation of human adipose tissue-derived stromal cells
    Da Sol Kim et al, 2015, Exp Mol Med CrossRef
19. MicroRNA signature predicts survival in papillary thyroid carcinoma
    Xiong Chengfeng et al, 2019, J Cell Biochem CrossRef
20. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299–3p/VEGF axis in vitro and in vivo
    Yunsheng Li et al, 2019, European Journal of Pharmacology CrossRef
21. CD117: A novel ancillary marker for papillary thyroid carcinoma in fine-needle aspiration biopsies
    Marc P. Pusztaszeri et al, 2014, Cancer Cytopathology CrossRef
22. The combination of TP53INP1, TP53INP2 and AXIN2: potential biomarkers in papillary thyroid carcinoma
    Mengzi He et al, 2015, Endocrine CrossRef
23. Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions
    Yongming Xu et al, 2014 CrossRef
24. Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis.
    Daniel G Weber et al, 2014, PLoS One CrossRef
25. The roles of AXIN2 in tumorigenesis and epigenetic regulation
    Shuang Li et al, 2015, Familial Cancer CrossRef
26. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer
    Preethi Krishnan et al, 2015, BMC Genomics CrossRef
27. Global profiling of the signaling network of papillary thyroid carcinoma
    Kaijun Huang et al, 2016, Life Sciences CrossRef
28. Role of gene expression profiling in defining indeterminate thyroid nodules in addition toBRAFanalysis
    Nicla Borrelli et al, 2016, Cancer Cytopathology CrossRef
29. Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review, meta-analysis, and experimental validation
    Yiren Hu et al, 2016, Cancer Med CrossRef
30. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC.
    Jianxia Hu et al, 0 CrossRef
31. Inhibition of TUG1/miRNA-299-3p Axis Represses Pancreatic Cancer Malignant Progression via Suppression of the Notch1 Pathway
    Ke Xu et al, 2019, Dig Dis Sci CrossRef
32. Upregulation of microRNA-143-3p induces apoptosis and suppresses proliferation, invasion, and migration of papillary thyroid carcinoma cells by targeting MSI2
    Zheng-Lin Wang et al, 2019, Experimental and Molecular Pathology CrossRef
33. Inhibitory effects of miR‑26b‑5p on thyroid cancer
    Aiya Zhou et al, 2019, Mol Med Report CrossRef
34. Competing endogenous RNA regulatory network in papillary thyroid carcinoma
    Shouhua Chen et al, 2018, Mol Med Report CrossRef
35. Ang1/Tie2 induces cell proliferation and migration in human papillary thyroid carcinoma via the PI3K/AKT pathway.
    Ke Ye et al, 0 CrossRef
36. Bioinformatics analysis to screen key genes in papillary thyroid carcinoma
    Yuanhu Liu et al, 2019, Oncol Lett CrossRef
37. The Alterations and Potential Roles of MCMs in Breast Cancer
    Xinyu Liu et al, 2021, Journal of Oncology CrossRef
38. Integrated Analysis of Mutations, miRNA and mRNA Expression in Glioblastoma
    ShiChao Wang et al, 2021, IJGM CrossRef
39. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks
    Gizem Gulfidan et al, 2021, Archives of Biochemistry and Biophysics CrossRef
40. MicroRNA-101 Targets CXCL12-Mediated Akt and Snail Signaling Pathways to Inhibit Cellular Proliferation and Invasion in Papillary Thyroid Carcinoma
    Fang Chen et al, 2019, oncol res CrossRef
41. MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment
    Maria Papaioannou et al, 2022, Front. Oncol. CrossRef
42. PAIP1 is a novel oncogene in human hepatocellular carcinoma
    Nuobei Zhang et al, 2022, Discov Onc CrossRef
43. Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer
    Tristan Joseph Verhoeff et al, 2022, Cell Oncol. CrossRef
44. Profile of MicroRNAs Associated with Death Due to Disease Progression in Metastatic Papillary Thyroid Carcinoma Patients
    Ana Kober Leite et al, 2023, Cancers CrossRef
45. miRNAs as Epigenetic Cancer Biomarker
    Afraa Mamoori, 2023 CrossRef
46. Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer
    Viviana A. Ruiz-Pozo et al, 2023, Front. Med. CrossRef
47. LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/HMGA2 expression
    Zhaohui Zeng et al, 2023, Aging CrossRef